01 — At a Glance
The MFI That Paid Dues to Karnataka and Got Nothing in Return
- 52-Week High / Low₹210 / ₹119
- Q3 FY26 Revenue₹603 Cr
- Q3 FY26 PAT₹62.4 Cr
- Q3 EPS₹3.66
- TTM EPS₹-17.72
- Book Value / Share₹158
- Price to Book0.95x
- Gross NPA (Dec 2025)4.40%
- Net NPA (Dec 2025)1.34%
- AUM (Dec 2025)₹13,078 Cr
Flash Summary: Muthoot Microfin has the oddest financial horror movie arc. FY25: lost ₹223 crore. Q1 FY26: lost ₹401 crore (Karnataka pain). Q2-Q3: slowly clawing back to ₹62 crore profit in Q3. Stock is down 16% in 3 months. Trading at 0.95x book value—which means the market thinks your balance sheet is worth less than paper. And yet… management is convinced this is a redemption story, not a funeral.
02 — Introduction
How To Turn Your Best Year (2024) Into Your Worst Year (2025), A Masterclass by Muthoot
Founded in 1992, Muthoot Microfin is a subsidiary of the Muthoot Pappachan Group and ranks as India’s 2nd largest NBFC-MFI by gross loan portfolio. They lend to women in rural regions. Noble goal. Sound business model historically. Then 2024 happened, and Karnataka decided that borrower stress was actually Muthoot’s problem to solve.
The company IPO’d in December 2023, raising ₹960 crores and getting listed with great fanfare. Q3 FY25 (Dec 2024): GNPA was a manageable 2.29%. Fast forward to Q4 FY25 (Mar 2025): a provision surprise hit. TTM PAT for FY25 ended at negative ₹223 crore. Translation: they paid a ₹401 crore management overlay in Q1 FY26 alone for Karnataka pain.
Now Q3 FY26 (Dec 2025): PAT is ₹62 crore. A full 9 months later and they’re barely profitable. GNPA has bloated to 4.40%. AUM growth is slowing to mid-single digits. And the stock has collapsed 16% in three months. The market is asking a simple question: Is the worst over, or are we still in the movie?
The IPO Plot Twist: Muthoot IPO’d at ₹600 a share in December 2023. Today it trades at ₹151. That’s a 75% haircut in just 14 months. The prospectus promised growth, returns, and a burgeoning rural lending opportunity. What arrived instead was Karnataka, an audit shock, and a management team that now explains losses as “investments in the future.” Welcome to post-IPO reality.
03 — Business Model: Lending to Women. Losing to States.
Joint Liability Groups: Genius Until They Aren’t
Muthoot’s business is microfinance—lending small sums (typically ₹20k–₹200k) to women borrowers in rural and semi-urban India, organized into Joint Liability Groups (JLGs). The JLG model is elegant: borrowers co-guarantee each other, peer pressure replaces collateral, and repayment rates historically hovered around 98%+.
The loan book was 88% JLG / 12% non-JLG as of Q3 FY26. Management is strategically diversifying: individual loans (Muthoot Small & Growing Businesses), micro-LAPs (secured), and gold loan referrals. Good prudence. 1,699 branches across 18 states. 3.43 million active customers. Revenue model: earn spread between borrowing costs (~10.4%) and lending yields (~23% for group loans, ~23% for individual, ~20% for LAP). Typical MFI playbook.
Where it breaks: when entire geographies (like Karnataka) simultaneously face stress—crop failures, inflation, government schemes that discourage repayment—the whole JLG model implodes because everyone defaults together. Your co-guarantor can’t help if both of you have no income. The 98% repayment rate becomes 85%, then 75%, and your balance sheet gets a ₹401 crore surprise.
JLG Loans88%of portfolio
Non-JLG Loans12%diversifying fast
Active Customers3.43Mwomen borrowers
Branches1,699across 18 states
The Karnataka Albatross: In FY25-26, Karnataka contributed outsized stress. By Q3 FY26, Muthoot had slashed state exposure from 10% to 7% of AUM (from ~₹1,251 crore to ~₹915 crore). But the damage was structural. When a state decides that loan repayment is “anti-poor,” your JLG model becomes a fancy way to say “everyone owes us money but won’t pay.”
04 — Financials Overview
Q3 FY26: The Baby Steps Back to Viability
Result type: Quarterly Results | Q3 FY26 EPS: ₹3.66 | Q1-Q3 EPS avg: (₹-23.53 + ₹0.36 + ₹3.66)/3 = ₹-6.50 | Annualised EPS (impaired): ₹-26.00
| Metric (₹ Cr) |
Q3 FY26
Dec 2025 |
Q3 FY25
Dec 2024 |
Q2 FY26
Sep 2025 |
YoY % |
QoQ % |
| Revenue | 603 | 577 | 576 | +4.5% | +4.7% |
| Financing Profit | 77 | 15 | 47 | +413% | +63.8% |
| Financing Margin % | 13% | 2% | 8% | +1100 bps | +500 bps |
| PAT | 62.4 | 4 | 31 | +1,510% | +101% |
| EPS (₹) | 3.66 | 0.22 | 1.79 | +1,563% | +104% |
The Reversal Math: Q3 FY25 had a measly ₹4 crore PAT because of stress. Q3 FY26 has ₹62 crore. The 1,500%+ jump looks insane until you realize the denominator was near-zero. PAT is still off by ₹40 crore compared to FY24-era Q3 normalcy (₹125 crore in Q3 FY25 was exceptional). The company is clawing back to maybe 50% of historical profitability. That’s not a recovery. That’s triage.
💬 A 1,500% YoY jump in EPS sounds like a pump-and-dump setup headline. But we all know the base was devastated. So here’s the real question: does management’s conviction that FY26 will close “close to 2% ROA” sound credible, or are we about to get surprised again?
05 — Valuation Discussion – Fair Value Range Only
What Is This Wounded Lender Actually Worth?
